134 related articles for article (PubMed ID: 23611568)
1. Population pharmacokinetic study of cyclosporine in the hematopoietic stem cell transplant recipients.
Zhou Y; Sheng XY; Xu JY; Bi SS; Lu W; Cui YM
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):568-75. PubMed ID: 23611568
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic study of cyclosporine based on NONMEM in Chinese liver transplant recipients.
Sun B; Li XY; Gao JW; Rui JZ; Guo YK; Peng ZH; Liu GL
Ther Drug Monit; 2010 Dec; 32(6):715-22. PubMed ID: 21068646
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.
Jacobson PA; Ng J; Green KG; Rogosheske J; Brundage R
Biol Blood Marrow Transplant; 2003 May; 9(5):304-11. PubMed ID: 12766880
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
Li TF; Hu L; Ma XL; Huang L; Liu XM; Luo XX; Feng WY; Wu CF
Acta Pharmacol Sin; 2019 Dec; 40(12):1603-1610. PubMed ID: 31341257
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetic Modeling of Cyclosporine Among Malaysian Renal Transplant Patients: An Evaluation of Methods to Handle Missing Doses in Conventional Drug-Monitoring Data.
Albitar O; Ballouze R; Harun SN; Mohamed Noor DA; Sheikh Ghadzi SM
J Clin Pharmacol; 2020 Nov; 60(11):1474-1482. PubMed ID: 32557653
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.
Schrauder A; Saleh S; Sykora KW; Hoy H; Welte K; Boos J; Hempel G; Grigull L
Pediatr Transplant; 2009 Jun; 13(4):444-50. PubMed ID: 18482216
[TBL] [Abstract][Full Text] [Related]
8. Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals.
Atiq F; Hameli E; Broers AEC; Doorduijn JK; Van Gelder T; Andrews LM; Koch BCP; Versmissen J; de Winter BCM
Eur J Clin Pharmacol; 2018 Jun; 74(6):767-773. PubMed ID: 29500599
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance.
Ling J; Yang XP; Dong LL; Jiang Y; Zou SL; Hu N; Chen R
J Clin Pharm Ther; 2022 Apr; 47(4):483-492. PubMed ID: 34779003
[TBL] [Abstract][Full Text] [Related]
10. Limited sampling strategies for estimating intravenous and oral cyclosporine area under the curve in pediatric hematopoietic stem cell transplantation.
Sarem S; Nekka F; Barrière O; Bittencourt H; Duval M; Teira P; Haddad E; Théorêt Y; Lapeyraque AL; Litalien C
Ther Drug Monit; 2015 Apr; 37(2):198-205. PubMed ID: 25162214
[TBL] [Abstract][Full Text] [Related]
11. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.
Falck P; Midtvedt K; Vân Lê TT; Storehagen L; Holdaas H; Hartmann A; Asberg A
Clin Pharmacokinet; 2009; 48(9):615-23. PubMed ID: 19725595
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms.
Kim MG; Kim IW; Choi B; Han N; Yun HY; Park S; Oh JM
Ann Pharmacother; 2015 Jun; 49(6):622-30. PubMed ID: 25818517
[TBL] [Abstract][Full Text] [Related]
13. NONMEM population pharmacokinetic modeling of orally administered cyclosporine from routine drug monitoring data after heart transplantation.
Parke J; Charles BG
Ther Drug Monit; 1998 Jun; 20(3):284-93. PubMed ID: 9631925
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients.
Zhou H; Gao Y; Cheng XL; Li ZD
Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):271-8. PubMed ID: 22446981
[TBL] [Abstract][Full Text] [Related]
16. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.
Eljebari H; Gaies E; Fradj NB; Jebabli N; Salouage I; Trabelsi S; Lakhal M; Klouz A
Eur J Clin Pharmacol; 2012 Nov; 68(11):1517-24. PubMed ID: 22527344
[TBL] [Abstract][Full Text] [Related]
18. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].
Xue L; Rui JZ; Zhang Y; Miao LY
Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140
[TBL] [Abstract][Full Text] [Related]
19. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of cyclosporine in chinese cardiac transplant recipients.
Yin OQ; Lau SK; Chow MS
Pharmacotherapy; 2006 Jun; 26(6):790-7. PubMed ID: 16716132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
